The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / NYU Langone’s Division of Rheumatology in Manhattan Advances Its Mission to Understand Rheumatic Diseases, Improve Patient Outcomes

NYU Langone’s Division of Rheumatology in Manhattan Advances Its Mission to Understand Rheumatic Diseases, Improve Patient Outcomes

October 10, 2016 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Division Director Jill P. Buyon, MD, left, and Professor Emeritus and former Division Director Gerald Weissmann, MD, right, speak at a Rheumatology Grand Rounds at NYU Langone.

Division Director Jill P. Buyon, MD, left, and Professor Emeritus and former Division Director Gerald Weissmann, MD, right, speak at a Rheumatology Grand Rounds at NYU Langone.

From its beginnings as the Rheumatic Diseases Study Group (RDSG) in the early 1930s, NYU Langone Medical Center’s Division of Rheumatology has been built on a tradition of research and clinical care. Today’s division, with 24 full-time and 76 part-time faculty members, continues to push toward understanding the pathogenesis of rheumatic diseases and interventions to improve outcomes.

You Might Also Like
  • Quality Measures Used to Assess Care, Improve Outcomes in Children, Adults with Rheumatic Diseases
  • Lupus Treatment Advances Lag Behind Other Rheumatic Diseases
  • Mind-Body Focus Can Improve Treatment, Outcomes in Rheumatic Disease
Explore This Issue
October 2016
Also By This Author
  • Summer 2019’s Awards, Appointments & Announcements in Rheumatology

For example, in addition to her National Institutes of Health (NIH) supported lupus laboratory and studies on neonatal lupus, Division Director Jill P. Buyon, MD, the Lady Va and Sir Deryck Maughan Professor of Rheumatology, recently published the results of a multi-center study of the risks of pregnancy in mothers with lupus. In another laboratory, José U. Scher, MD, assistant professor, Department of Medicine, and colleagues explore the connection between the microbiome and psoriatic arthritis.

Jill P. Buyon, MD,  Division Director

Jill P. Buyon, MD,
Division Director

At the seven affiliated outpatient hospitals, ranging from Bellevue Hospital to the Manhattan VA to NYU Langone’s Tisch Hospital and Hospital for Joint Diseases, clinicians and trainees encounter diverse patient populations that contribute to the depth of research for understanding the early diagnosis and treatment of rheumatic conditions.

A tradition of basic science exploration, married to the diversity of patient populations, defines NYU Langone’s Division of Rheumatology as a top U.S. division, notes Gerald Weissmann, MD, professor emeritus of medicine, past president of ACR, who was director of the division from 1973 to 2000.

José U. Scher, MD,  Assistant Professor, Department of Medicine

José U. Scher, MD,
Assistant Professor, Department of Medicine

It was this combination that drew Gregg Silverman, MD, professor, Department of Medicine and Department of Pathology, to move from his former post as a professor at the University of California, San Diego and an adjunct member of the Department of Molecular and Experimental Medicine at The Scripps Research Institute in La Jolla. “NYU Langone has the most remarkable clinical facilities and we provide the highest standard of clinical care,” Dr. Silverman remarks. “There can be no better place for studying lupus and related autoimmune diseases than New York City.”

Training & Retaining Talent

The Division’s longstanding training program, established as a formal ACGME (Accreditation Council for Graduate Medical Education) program in 1986 by Steven B. Abramson, MD, who later became division director, currently includes eight fellows. Dr. Abramson is now the Frederick H. King Professor of Internal Medicine and chair, Department of Medicine, and vice dean for education faculty & academic affairs at NYU Langone.

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Education & Training, Profiles Tagged With: Education, goals, Manhattan, NYU Langone, outcome, patient care, Research, Rheumatic Disease, rheumatologist, rheumatology, TrainingIssue: October 2016

You Might Also Like:
  • Quality Measures Used to Assess Care, Improve Outcomes in Children, Adults with Rheumatic Diseases
  • Lupus Treatment Advances Lag Behind Other Rheumatic Diseases
  • Mind-Body Focus Can Improve Treatment, Outcomes in Rheumatic Disease
  • Stem Cell Transplantation Shown to Improve Outcomes in Systemic Sclerosis

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.